Apotex, Slayback Beat Lymphoma Drug Patent Suit In Del.
A Delaware federal judge cleared pharmaceutical companies Apotex and Slayback of patent infringement claims lodged by the maker of cancer drug Belrapzo over their new drug applications, ruling that the disputed...To view the full article, register now.
Already a subscriber? Click here to view full article